NRX Pharmaceuticals (NRXP) Return on Capital Employed Growth (1y) (2019 - 2026)
NRX Pharmaceuticals (NRXP) Return on Capital Employed Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 470.64 Bn | 465.84 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.91 Bn | 115.67 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - | - |
| 8 | Argenx Se | 56.21 Bn | 51.02 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.60 Bn | 37.60 Bn | - | -3,457.00 |
| 10 | NRX Pharmaceuticals | 119.60 Mn | 112.90 Mn | 437,000.00 | 7,404.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,404.00 |
| Dec 31, 2025 | 721.00 |
| Sep 30, 2025 | -8,691.00 |
| Dec 31, 2024 | -14,791.00 |
| Sep 30, 2024 | -83,443.00 |
| Dec 31, 2023 | 70,722.00 |
| Dec 31, 2022 | -2,759.00 |
| Dec 31, 2021 | -54,847.00 |
| Sep 30, 2021 | 230,889.00 |
| Jun 30, 2021 | 21,082.00 |
| Dec 31, 2020 | 12,262.00 |
| Sep 30, 2020 | -9,005.00 |
| Jun 30, 2020 | -404.00 |
| Mar 31, 2020 | -142.00 |
| Sep 30, 2019 | -54.00 |